- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01844479
Multi-layer Insoles for a Patient-specific Approach to Shear and Pressure Reduction in Diabetes-related Foot Ulcer
Multi-material, Layer, and Density Insoles for a Patient-specific Approach to Shear and Pressure Reduction in the Treatment and Prevention of Diabetes-related Foot Ulcer
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Device Description: The Dynamic Foot Orthosis (DFO) is designed with a rolling link mechanism at the distal 3rd. It is designed to reduce sliding friction and torque at the metatarsal heads in addition to decreasing compressive forces that is accomplished by the conventional multi-durometer FOs. The relative sliding motion of two compliant surfaces over each other allows some deformation horizontally and lowers frictional resistance. The DFO addresses the friction element by accommodating the normal sliding and rolling motion at the distal 3rd of the foot during gait. Additionally, the DFO has a silicone layer at the metatarsal head and the remainder of the anterior section made of 2 separated orthotic layers that slide over each other. This provides an articulating surface to provide a relative motion between the orthotic segments while transmitting load.
Study Objectives: In this pilot study, the first objective is to bench test a novel shear reducing insole and compare it to current standard insoles and shoes. The second objective is to study twenty-seven insensate diabetes patients with pre-ulcerative foot callus to examine for changes in spatial temporal gait including gait initiation, risk of falling, static and dynamic balance, and plantar temperature response to walking and consecutive plantar stress in both footwear conditions.
Study Design: This is an interventional study. For objective one, changes in compression stiffness and static coefficients of friction will be measured using a force dynamometer in the lab of Professor Albert Shih. A test platform will be built to evaluate the performance of the shear reduction shoe sole design and characteristic of the force, in two directions parallel (shear) and perpendicular to the ground, and the associated deformation under the steady-state and impulse conditions.
For objective two, diabetes patients presenting to the Michigan Orthotics and Prosthetics Center for fabrication and dispensing of diabetic shoes and innersoles will be invited to participate. Twenty-seven insensate diabetes patients with pre-ulcerative foot callus will be enrolled. Patients will wear body worn sensors (LegSys) to measure changes in spatial-temporal gait and static and dynamic balance parameters prior and post usage of the insoles. To reduce the effects of learning from naïve use of novel footwear, the testing sequence between the experimental and standard footwear will be randomized. We will examine increase on foot temperature over 200 steps of continuous walking using the DFO and using standard insoles. We will also examine if the thermal changes are mediated by autonomic neuropathy as measured by sudomotor function. The footwear testing sequence will be randomized and an acclimatization procedure will be followed in an effort to minimize the potential effects of cumulative plantar temperature responses to walking and footwear conditions. We will also examine static balance by measuring center of mass with eyes open and eyes closed condition.
Outcome Measures: For objective one, the primary endpoints will be the compression stiffness and static coefficients of friction. For objective two, plantar foot temperature changes in regions-of-interest in response to walking 200 steps will be measured in each footwear condition and compared to baseline. Other outcome measures include gait analysis, including gait initiation, gait speed, double support time, medial and lateral center of mass displacement, and inter-cycle variability under single and dual task conditions. This will be measured during each footwear condition. Static balance will also be measured in each footwear condition. Using the Romberg's test, we will also assess center of mass displacement and reciprocal hip and ankle motion under eyes open and closed conditions. Sudomotor function will be measured by electrical sweat conductance (ESC), as expressed in microSiemens (µS).
Safety Evaluation: All subjects who sign the informed consent form and are determined to be eligible for treatment will be included in the analysis of safety. Collection, classification and summary analysis of adverse events will be performed.
Duration of Participation: One visit lasting approximately 1 hour.
Duration of Study: One year
Inclusion Criteria: Patients will be included if they have diabetes and have been referred for diabetic shoes. They will also be insensate with pre-ulcerative plantar callus or previous plantar foot ulcer.
Exclusion Criteria: Patients will be excluded if they are unable to independently walk 100 feet, lower extremity prosthesis user, have active cellulitis, foot ulcer, or Charcot foot.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Michigan
-
Ann Arbor, Michigan, United States, 48104-6768
- Michigan Orthotics and Prosthetics
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients will be included if they have diabetes and have been referred for diabetic shoes. They will also be insensate with pre-ulcerative plantar callus or previous plantar foot ulcer.
Exclusion Criteria:
- Patients will be excluded if they are unable to independently walk 100 feet, lower extremity prosthesis user, have active cellulitis, foot ulcer, or Charcot foot.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Standard innersole
Per sequence cross over design. Order of testing innersoles was randomized and each testing condition lasted 15 minutes. The industry standard diabetic innersole will be used as the active comparator |
|
Experimental: Diabetic Foot Orthotic
The Dynamic Foot Orthosis (DFO) is designed with a rolling link mechanism at the distal 3rd to reduce sliding friction at the metatarsal heads in addition to decreasing compressive forces.
The relative sliding motion of two compliant surfaces over each other allows some deformation horizontally and lowers frictional resistance.
The DFO addresses the friction element by accommodating the normal sliding and rolling motion at the distal 3rd of the foot during gait.
Additionally, the DFO has a silicone layer at the metatarsal head and the remainder of the anterior section made of 2 separated orthotic layers that slide over each other.
This provides an articulating surface to provide a relative motion between the orthotic segments while transmitting load.
|
The Dynamic Foot Orthosis (DFO) is designed with a rolling link mechanism at the distal 3rd to reduce sliding friction at the metatarsal heads in addition to decreasing compressive forces.
The relative sliding motion of two compliant surfaces over each other allows some deformation horizontally and lowers frictional resistance.
The DFO addresses the friction element by accommodating the normal sliding and rolling motion at the distal 3rd of the foot during gait.
Additionally, the DFO has a silicone layer at the metatarsal head and the remainder of the anterior section made of 2 separated orthotic layers that slide over each other.
This provides an articulating surface to provide a relative motion between the orthotic segments while transmitting load.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Plantar Foot Temperature Changes in Regions-of-interest in Response to Walking
Time Frame: baseline and after 200 steps in each condition, this is a single visit study expected to last one hour
|
Plantar foot temperature changes in regions-of-interest in response to walking 200 steps will be measured in each footwear condition and compared to baseline.
|
baseline and after 200 steps in each condition, this is a single visit study expected to last one hour
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Gait Initation - Single Task
Time Frame: during each foot wear condition up to 30 minutes
|
The number of steps taken to reach steady state walking under single task.
Single task means walking without a simultaneous mental task.
|
during each foot wear condition up to 30 minutes
|
Gait Initiation - Dual Task
Time Frame: during each foot wear condition up to 30 minutes
|
The number of steps taken to reach steady state walking under dual task.
Dual task used a simultaneous mental task while walking.
|
during each foot wear condition up to 30 minutes
|
Stride Velocity - Dual Task
Time Frame: during each foot wear condition up to 30 minutes
|
Stride velocity during steady state dual task.
Dual task used a simultaneous mental task while walking.
|
during each foot wear condition up to 30 minutes
|
Double Support Time Single Task
Time Frame: during each foot where condition up to 30 minutes
|
percentage of stride time spent in double support time during gait initiation.
Double support time refers to the time spent with both feet on the ground.
Single task means walking without a simultaneous mental task.
|
during each foot where condition up to 30 minutes
|
Double Support Time Dual Task Gait Initiation
Time Frame: during each foot where condition up to 30 minutes
|
percentage of stride time spent in double support time during dual task conditions and during gait initiation.
Double support time refers to the time spent with both feet on the ground.
Dual task used a simultaneous mental task while walking.
|
during each foot where condition up to 30 minutes
|
Medial and Lateral Center of Mass Displacement Single Task
Time Frame: under each foot where condition up to 30 minutes
|
Mediolateral (side-to-side) center of mass displacement with displacement in deg2 (degrees squared) under single task gait conditions.
Single task means walking without a simultaneous mental task.
|
under each foot where condition up to 30 minutes
|
Medial and Lateral Center of Mass Displacement Dual Task
Time Frame: both footwear conditions up to 30 minutes
|
Mediolateral (side-to-side) center of mass displacement in deg2 (degrees squared) under dual task gait.
Dual task used a simultaneous mental task while walking.
|
both footwear conditions up to 30 minutes
|
Gait Speed Variability Single Task
Time Frame: both footwear conditions up to 30 minutes
|
Gait speed variability (estimated using coefficient and variation of stride velocity) Single task means walking without a simultaneous mental task.
|
both footwear conditions up to 30 minutes
|
Gait Speed Variability Dual Task
Time Frame: Both footwear conditions up to thirty minutes
|
Gait speed variability (estimated using coefficient and variation of stride velocity) Dual task used a simultaneous mental task while walking.
|
Both footwear conditions up to thirty minutes
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Stride Velocity - Single Task
Time Frame: during each foot wear condition up to 30 minutes
|
Stride velocity steady state gait single task.
Single task means walking without a simultaneous mental task.
|
during each foot wear condition up to 30 minutes
|
Sudomotor Function
Time Frame: at baseline, this is a single visit study expected to last one hour
|
Sudomotor function will be measured by electrical sweat conductance (ESC), as expressed in microSiemens (µS).
|
at baseline, this is a single visit study expected to last one hour
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: James Wrobel, DPM, MS, UMHS
Publications and helpful links
General Publications
- Belmont B, Wang Y, Ammanath P, Wrobel JS, Shih A. An apparatus to quantify anteroposterior and mediolateral shear reduction in shoe insoles. J Diabetes Sci Technol. 2013 Mar 1;7(2):410-9. doi: 10.1177/193229681300700218.
- Wrobel JS, Ammanath P, Le T, Luring C, Wensman J, Grewal GS, Najafi B, Pop-Busui R. A novel shear reduction insole effect on the thermal response to walking stress, balance, and gait. J Diabetes Sci Technol. 2014 Nov;8(6):1151-6. doi: 10.1177/1932296814546528. Epub 2014 Aug 7.
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- HUM00059211 (Other Identifier: IRBMED)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diabetic Foot
-
University of PadovaUnknownDiabetic Foot | Diabetic Foot Ulcer | Diabetic Foot Infection | Diabetic Foot Ulcer Neuropathic | Deformities FootItaly
-
Johns Hopkins UniversityWithdrawnDiabetic Foot | Diabetic Foot Ulcer | Diabetic Foot Infection | Diabetic Foot Ulcer Mixed | Vascular Ulcer (Arterial or Venous Including Diabetic Ulcers Not Located on the Foot)
-
Integra LifeSciences CorporationMayo Clinic; Temple University; Samuel Merritt University; New York College of... and other collaboratorsCompletedFoot Ulcers, DiabeticUnited States
-
Community Pharmacology Services LtdKeneric HealthcareNot yet recruitingDiabetic Foot Ulcer | Diabetic Foot Ulcer Neuropathic | Diabetic Foot Ulcer Ischemic
-
Exciton Technologies Inc.CompletedDiabetic Foot Ulcer | Diabetic Foot Infection | Non-healing Diabetic Foot UlcerCanada
-
Corporacion Parc TauliCompletedDiabetic Foot Ulcer | Diabetic Foot Ulcer NeuropathicPakistan
-
University of the PunjabHigher Education Commission (Pakistan); Centre of Excellence in Molecular Biology... and other collaboratorsRecruitingDiabetes Mellitus | Diabetic Foot | Foot Ulcer | Diabetes Complications | Diabetic Foot Ulcer | Diabetic Foot Infection | Diabetic Foot Ulcer Neuropathic | Foot Ulcer Due to Type 1 Diabetes Mellitus | Foot Ulcer Due to Type 2 Diabetes Mellitus | Chronic Diabetic Ulcer of Left Foot | Chronic Diabetic Foot...Pakistan
-
University of MinnesotaRecruitingDiabetes Mellitus | Foot Ulcer | Ulcer | Diabetic Foot Ulcer | Foot Ulcer, Diabetic | Ulcer Foot | Ulcer, Leg | Ankle UlcerUnited States
-
HealthpointCompletedDiabetic Foot Ulcers | Diabetic Foot WoundsUnited States, Canada
-
HealthpointCompleted
Clinical Trials on Standard innersole
-
University of PennsylvaniaRestaurant AssociatesActive, not recruitingObesity | Weight Gain | Food Preferences | Food SelectionUnited States
-
HealthpointCompleted
-
Neuroscience Trials AustraliaNational Institute for Health Research, United Kingdom; Northern Ireland Chest... and other collaboratorsCompleted
-
University of MichiganEnrolling by invitationDepression | Anxiety | Sleep Disturbance | AddictionUnited States
-
Micro Medical Solution, Inc.RecruitingPeripheral Arterial DiseaseUnited States
-
Institute of Cardiology, Warsaw, PolandUnknownCardiac RehabilitationPoland
-
Avita MedicalNAMSACompletedVenous Leg UlcersUnited Kingdom, France
-
University of MichiganCompleted
-
University of OklahomaNational Cancer Institute (NCI)CompletedSmoking CessationUnited States
-
Yonsei UniversityCompletedMedical StudentsKorea, Republic of